Global Pharmaceuticals & Biotech Undervalued based on future growth

CSL

Market Cap: AU$48.6b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Royalty Pharma

Market Cap: US$30.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Grifols

Market Cap: €5.8b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

TG Therapeutics

Market Cap: US$5.6b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Amneal Pharmaceuticals

Market Cap: US$3.9b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Organon

Market Cap: US$3.5b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

China Medical System Holdings

Market Cap: HK$26.6b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Hypera

Market Cap: R$15.9b

Operates as a pharmaceutical company in Brazil.

Pharma Mar

Market Cap: €1.7b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

ADMA Biologics

Market Cap: US$2.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Harmony Biosciences Holdings

Market Cap: US$1.8b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.

ANI Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Zhejiang Jingxin Pharmaceutical

Market Cap: CN¥11.5b

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Lotus Pharmaceutical

Market Cap: NT$52.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$48.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Square Pharmaceuticals

Market Cap: ৳185.5b

Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥9.7b

A biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.

Luye Pharma Group

Market Cap: HK$8.9b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Strides Pharma Science

Market Cap: ₹106.8b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$8.3b

Shanghai Haohai Biological Technology Co., Ltd.

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥7.0b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Shandong Wit Dyne HealthLtd

Market Cap: CN¥6.5b

Engages in the pharmaceutical business in China.

Genomma Lab Internacional. de

Market Cap: Mex$15.5b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Omeros

Market Cap: US$896.0m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

SSY Group

Market Cap: HK$6.9b

An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$6.4b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

CorMedix

Market Cap: US$622.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Zevra Therapeutics

Market Cap: US$605.3m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Blau Farmacêutica

Market Cap: R$2.5b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Beximco Pharmaceuticals

Market Cap: ৳54.6b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Renata

Market Cap: ৳46.6b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

Viva Biotech Holdings

Market Cap: HK$2.9b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥53.6b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$464.9m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.